These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31668356)

  • 21. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS; Ostermann M; Forni L; Tidmarsh GF
    Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II in Vasodilatory Shock.
    Wakefield BJ; Busse LW; Khanna AK
    Crit Care Clin; 2019 Apr; 35(2):229-245. PubMed ID: 30784606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safe Use of Vasopressin and Angiotensin II for Patients with Circulatory Shock.
    Bauer SR; Sacha GL; Lam SW
    Pharmacotherapy; 2018 Aug; 38(8):851-861. PubMed ID: 29878459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II in septic shock.
    Jadhav AP; Sadaka FG
    Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin II (Giapreza): A Distinct Mechanism for the Treatment of Vasodilatory Shock.
    Khalique SC; Ferguson N
    Cardiol Rev; 2019; 27(3):167-169. PubMed ID: 30601161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catecholamine Vasopressor Support Sparing Strategies in Vasodilatory Shock.
    Buckley MS; Barletta JF; Smithburger PL; Radosevich JJ; Kane-Gill SL
    Pharmacotherapy; 2019 Mar; 39(3):382-398. PubMed ID: 30506565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support.
    Wieruszewski PM; Seelhammer TG; Barreto EF; Busse LW; Chow JH; Davison DL; Gaglani B; Khanna AK; Ten Lohuis CC; Mara KC; Wittwer ED
    J Intensive Care Med; 2023 May; 38(5):464-471. PubMed ID: 36524274
    [No Abstract]   [Full Text] [Related]  

  • 28. Angiotensin II in Refractory Septic Shock.
    Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
    Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasodilatory shock in the ICU and the role of angiotensin II.
    Wakefield BJ; Sacha GL; Khanna AK
    Curr Opin Crit Care; 2018 Aug; 24(4):277-285. PubMed ID: 29877879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II: a new approach for refractory shock management?
    Kimmoun A; Levy B
    Crit Care; 2014 Dec; 18(6):694. PubMed ID: 25645552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressors for shock.
    Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
    Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
    Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
    Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II - A Brief Review and Role in Severe SARS-COV-2 Sepsis.
    Carà GA; Pasin L; Alborino E; Zarbock A; Bellomo R; Landoni G
    J Cardiothorac Vasc Anesth; 2022 Dec; 36(12):4496-4500. PubMed ID: 35995637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraoperative Use of Angiotensin II for Severe Vasodilatory Shock During Liver Transplantation: A Case Report.
    Running K; Weinberg D; Trudo W; Sullivan CL; Patel GP
    A A Pract; 2021 Feb; 15(2):e01402. PubMed ID: 33577171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Clinical Review of Vasopressors in Emergency Medicine.
    Stampfl M; DeBlieux P
    J Emerg Med; 2024 Jul; 67(1):e31-e41. PubMed ID: 38789351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II Brings More Questions Than Answers.
    Farina N; Bixby A; Alaniz C
    P T; 2018 Nov; 43(11):685-687. PubMed ID: 30410284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II for the Treatment of Vasodilatory Shock.
    Khanna A; English SW; Wang XS; Ham K; Tumlin J; Szerlip H; Busse LW; Altaweel L; Albertson TE; Mackey C; McCurdy MT; Boldt DW; Chock S; Young PJ; Krell K; Wunderink RG; Ostermann M; Murugan R; Gong MN; Panwar R; Hästbacka J; Favory R; Venkatesh B; Thompson BT; Bellomo R; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Deane AM;
    N Engl J Med; 2017 Aug; 377(5):419-430. PubMed ID: 28528561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Updates in the Pharmacological Management of Sepsis and Septic Shock: A Systematic Review Focused on Fluid Resuscitation, Vasopressors, and Corticosteroids.
    Allen JM; Feild C; Shoulders BR; Voils SA
    Ann Pharmacother; 2019 Apr; 53(4):385-395. PubMed ID: 30404539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure.
    Møller MH; Claudius C; Junttila E; Haney M; Oscarsson-Tibblin A; Haavind A; Perner A
    Acta Anaesthesiol Scand; 2016 Nov; 60(10):1347-1366. PubMed ID: 27576362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.